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Comparison of plasmakinetic transurethral resection of 
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Purpose: To compare urethral stricture rates in comorbid patients undergoing plasmakinetic transurethral resection of the prostate 
(PK-TURP) and monopolar transurethral resection of the prostate (M-TURP) for benign prostatic hyperplasia. 
Methods: The data of 317 patients with comorbidities undergoing either PK-TURP or M-TURP from September 2008 to December 
2012 were retrospectively evaluated. Preoperative and postoperative 12-month International Prostate Symptom Score, maximal flow 
rate, postoperative International Index of Erectile Function scores, and urethral stricture rates were evaluated. 
Results: A total of 154 patients underwent M-TURP and 163 patients underwent PK-TURP. Urethral stricture rates were 6/154 in the 
M-TURP treatment arm and 17/163 in the PK-TURP treatment arm (P=0.000). In the presence of hypertension and/or coronary artery 
disease and/or diabetes mellitus, the risk of urethral stricture complication was significantly higher in the PK-TURP group than in the 
M-TURP group (P=0.000). 
Conclusions: The risk of urethral stricture increases with PK-TURP in elderly patients with a large prostate and concomitant 
hypertension and/or coronary artery disease and/or diabetes mellitus. Therefore, PK-TURP should be performed cautiously in this 
group of benign prostatic hyperplasia patients. 
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INTRODUCTION
For many years, monopolar transurethral resection of the 
prostate (M-TURP) has been the standard method for treating 
lower urinary tract symptoms (LUTS) resulting from benign 
prostatic hyperplasia (BPH) with immediate success in re-
lieving the obstruction and with improvement of symptoms 
and voiding variables in the long run [1]. The reasons for the 
worldwide acceptance of this method include not only its 
good results, but also the low incidence of complications [2]. 
Nevertheless, M-TURP still requires hospitalization and can 
be complicated by intraoperative bleeding, clot retention, and 
transurethral resection (TUR) syndrome [3]. M-TURP is lim-
ited to prostate glands weighing less than 100 g and is associ-
ated with significant complications and morbidity if a larger 
prostate is resected. Therefore, a demand for technological 
alternatives that can decrease the risks of M-TURP, such as 
hemorrhage or electrolyte disturbances and TUR syndrome, 
remains [3,4].
 In this context, plasmakinetic or bipolar technology has 
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mented or suspected prostate cancer, neurogenic bladder, 
bladder stone or diverticula, urethral stricture, and maximal 
bladder capacity >500 mL. None of the patients had a history 
of urethral catheterization. Patients with low maximum and 
average flow rates at the postoperative follow-up underwent 
cystoscopy so that urethral stricture could be diagnosed and 
treated by internal urethrotomy.
2. Equipment
The electroresection and coagulation for M-TURP were per-
formed with a standard tungsten wire loop by use of a high-
frequency current having a maximum cutting power of 200 W 
and coagulating power of 80 W. In the M-TURP application, a 
26-F resectoscope, a 30o wide-angled optic, a wire loop elec-
trode (Storz, Tuttlingen, Germany), and 1.5% glycine solution 
were used. The Gyrus Plasmakinetic System for PK-TURP 
consists of a generator and a cutting loop that does not differ 
in shape from a monopolar loop but has an active and return 
electrode on the same axis, separated by a ceramic insulator. 
A chip in the loop automatically adjusts the power setting of 
the generator for the best cutting and coagulating parameters. 
In the PK-TURP application, a 26-F resectoscope, a 30o wide-
angled optic, and saline solution were used. All operations 
were performed by using a similar technique under spinal or 
general anesthesia. A 22-F three-way urinary catheter was left 
in place after the operation for 3 days, and saline irrigation 
was continued until the effluent fluid was completely clear. 
3. Statistical analysis
Statistical analyses were performed by using SPSS ver. 17.0 
(SPSS Inc., Chicago, IL, USA). The results were analyzed by 
using descriptive statistics with the nonparametric Mann-
Whitney U-test and chi-square test (or Fischer exact test), 
where appropriate, to compare continuous variables and cat-
egorical data, respectively. For the multivariate analysis, the 
possible factors that were identified in the univariate analysis 
were analyzed to determine independent predictors of ure-
thral stricture. Hosmer-Lemeshow goodness-of-fit statistics 
were used to assess model fit. Differences were considered 
statistically significant at a P-value of less than 0.05.
RESULTS
One hundred fifty-four patients underwent M-TURP and 163 
patients PK-TURP. Comorbidities in both treatment arms 
were similar (Table 1). The mean ages of the M-TURP and PK-
TURP groups were 64.4±8.3 and 69.0±8.0 years, respectively 
(P=0.00). Prostate volumes were 42.6 ±12.6 mL in the PK-
recently gained worldwide attention, with the aim of mini-
mizing the morbidity of the standard M-TURP procedure 
while maintaining efficacy and durability [5]. Unlike M-TURP, 
bipolar technologies allow the electric current to complete 
the circuit without passing through the patient. This allows 
saline solution to be used instead of glycine for irrigation dur-
ing resection. Thus, it reduces the risk of hyponatremia during 
TURP [5]. A concern for the occurrence of urethral stricture 
that could be a specific pitfall of plasmakinetic transurethral 
resection of the prostate (PK-TURP) was raised in recent years 
as the increasing number of patients with this complication 
became clinically relevant and alarming, even though the 
urethral stricture rate in the PK-TURP group compared with 
the M-TURP group was not statistically significant [6]. This 
issue was also noticed in our previous study [7]. However, 
although urethral stricture rates were higher in the PK-TURP 
group, statistical significance was not reached, probably 
because of the limited number of patients. Therefore, in the 
present study, a larger sample of patients undergoing either 
M-TURP or PK-TURP with similar technical equipment and 
clinical conditions was included in our series with the aim of 
obtaining sufficient data to evaluate the significance of the 
urethral stricture rate in the PK-TURP arm. 
MATERIALS AND METHODS 
1. Study design
The data of 317 patients with comorbidities who underwent 
either PK-TURP or M-TURP in two institutions (Taksim Teach-
ing Hospital and Maltepe University Hospital, Istanbul, Tur-
key) from September 2008 to December 2012 were retrospec-
tively evaluated. Formal study approval by the Institutional 
Review Board of Maltepe University (MAL.UN.KAEK/MEG.27. 
2011/22) was obtained. Data for preoperative International 
Prostate Symptom Score (IPSS), maximal flow rate (Qmax), 
residual urine volume, International Index of Erectile Function 
(IIEF), and comorbidities such as hypertension (HT), coronary 
artery disease (CAD), diabetes mellitus (DM), and chronic ob-
structive pulmonary disease (COPD) were reviewed. Sodium 
levels before the procedure and at 2 hours and hemoglobin 
levels before and at 24 hours were recorded postoperatively. 
Treatment efficacy was evaluated at 12 months postoperative-
ly by comparing Qmax, IPSS, IIEF scores, and urethral stricture 
rates. Inclusion criteria were age >50 years, good performance 
status, acute urinary retention if catheter removal failed after 
therapy with alpha-blockers or chronic urinary retention un-
responsive to medical treatment, IPSS≥8, and Qmax≤15 mL/
sec. Exclusion criteria were prostate volume <30 cm3, docu-
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ment arms (20.0±5.0 vs. 19.1±6.2, respectively). The urethral 
stricture rate was significantly higher in the PK-TURP group 
(17/163) than in the M-TURP group (6/154) (P=0.025) (Fig. 1). 
 When the univariate analysis was performed, age, prostate 
volume, and comorbidities were found to be risk factors for 
urethral stricture. Because age and prostate volume were 
significantly different in both treatment arms, this result 
should be regarded as a selection bias. However, regardless 
of the operation modalities, when prostate volume is larger 
than 80 mL, the risk of urethral stricture increases (P= 0.000). 
Particularly in the presence of HT and/or CAD and/or DM, 
the risk was significantly higher in the PK-TURP group than 
in the M-TURP group (P< 0.05) (Table 3). When multivariate 
analysis including the factors that were statistically significant 
in the univariate analysis was performed, it was observed that 
HT+DM and HT+DM+CAD were statistically powerful pre-
dictive factors for urethral stricture occurrence (Table 4). No 
bladder neck stricture was seen among patients at 12 months 
postoperatively.
DISCUSSION
The average lifespan in elderly men has been extended with 
advances in health care accessibility and diagnostic and treat-
ment modalities in the past decades [8]. However, this advan-
tage has come with an increase in age-related diseases, such 
as BPH. High-risk patients with BPH are defined as elderly 
TURP and 72.2 ±25.4 mL in the M-TURP group, respectively 
(P=0.00). Preoperative IPSS scores were 19.3 ±7.9 in the 
M-TURP and 25.6 ±7.6 in the PK-TURP group, respectively 
(P=0.00). There were no significant differences in terms of 
preoperative IIEF scores, Qmax, or postvoid residual between 
the two groups (Table 2). The operative times were 60.8±17.2 
and 60.0±23.5 minutes, respectively (P=0.17). The mean dif-
ference in Hb level at the 24-hour follow-up (g/dL) was lower 
in the PK-TURP group than in the M-TURP group (–1.4 ±1.1 
and –2.0 ±1.0, respectively, P=0.00). Four patients in the M-
TURP group required blood transfusion. The mean differ-
ence in serum sodium level at the 2-hour follow-up (mg/dL) 
was lower in the PK-TURP group (–4.4 ±4.3 and –10.8 ±4.4, 
respectively, P=0.00). The catheterization time and length of 
hospital stay were 3 days irrespective of the operation modali-
ties. Serum creatinine levels were 1.1 ±0.2 mg/dL in the M-
TURP and 1.2±0.2 mg/dL the in PK-TURP arm. At 12 months 
postoperatively, IPSS was lower whereas IIEF scores were 
higher in PK-TURP patients than in M-TURP patients (M-
TURP, 10.0 ±7.4 vs. PK-TURP, 8.3 ±7.3, P=0.00; and M-TURP, 
16.0±6.4 vs. PK-TURP, 18.2±8.7, P=0.00, respectively). Qmax 
values were similar in both M-TURP and PK-TURP treat-
Table 1. Distribution of comorbidities in M-TURP and PK-TURP 
patients 
Comorbidity
Operation modality
Total
M-TURP PK-TURP
HT 68 72 140
HT+CAD 12 15 27
COPD 16 14 30
DM 15 12 27
HT+COPD 5 8 13
HT+CAD+DM 18 20 38
HT+CAD+COPD 7 6 13
HT+DM 10 13 23
HT+DM+COPD 1 2 3
DM+COPD 2 1 3
Total 154 163 317
P-value 0.978
M, monopolar; PK, plasmakinetic; TURP, transurethral resection of the 
prostate; HT, hypertension; CAD, coronary artery disease; COPD, chronic 
obstructive pulmonary disease; DM, diabetes mellitus. 
Fig. 1. Percentage of urethral stricture in the treatment arms. M, 
monopolar; PK, plasmakinetic; TURP, monopolar transurethral 
resection of the prostate. *P=0.025.
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Table 2. Preoperative characteristics of the patients 
Operation modality Age (yr) Prostate volume (mL) IPSS Qmax (mL/sec) PVR volume (mL) IIEF
M-TURP (n=154) 64.4±8.3 42.6±12.6 19.3±7.9 8.7±2.8 122.0±61.0 16.8±6.3
PK-TURP (n=163) 69.0±8.0 72.2±25.4 25.6±7.6 8.5±4.2 131.5±73.7 15.1±8.5
P-value 0.00 0.00 0.00 0.96 0.51 0.23
M, monopolar; PK, plasmakinetic; TURP, transurethral resection of the prostate; IPSS, International Prostate Symptom Score; Qmax, maximum flow rate; 
PVR, postvoid residual; IIEF, International Index of Erectile Function.
Sinanoglu, et al. Urethral stricture in PK-TURP vs. M-TURP
124
PROSTATE INTERNATIONAL
http://dx.doi.org/10.12954/PI.14043
patients with concomitant cardiovascular, pulmonary, and 
other organ diseases. These patients are at a significant risk of 
complications during surgery [9]. Although several authors 
have reported that a conservative treatment is sufficient to 
relieve LUTS in elderly comorbid patients with BPH, the long-
term therapeutic effect is poor and the potential of symptom 
recurrence is high, especially in cases with large prostate vol-
umes [10]. 
 In recent years, the number of elderly BPH patients with 
comorbidities who meet the criteria for recommended sur-
gery has increased [11]. Therefore, surgical procedures that 
will provide the safest and most efficient outcomes in this 
subset of the population become necessary. M-TURP still 
represents the gold standard in the operative management 
of BPH. However, this procedure has complications such as 
hemorrhage or electrolyte disturbances (TUR syndrome), 
perforation, and long-term urethral strictures [12,13]. To re-
duce the complications of M-TURP, various electroresection 
technologies have been introduced with varying success. 
PK-TURP using bipolar energy has demonstrated promising 
early results among these modalities. Its perioperative results 
are comparable with those obtained with M-TURP, whereas 
its postoperative outcomes are more favorable [14,15]. The 
saline solution used for irrigation in PK-TURP reduces the 
possibility of TUR syndrome. The bipolar current has no 
impact on heart electrophysiology and ensures the safety of 
the operation. Finally, PK-TURP has been demonstrated to 
be more effective than M-TURP in resecting large volumes of 
prostate tissue [16]. These above-mentioned factors suggest 
that PK-TURP is a reliable resection modality in the elderly 
and comorbid patients having large prostates.
 Taking into consideration the results of previous studies 
reporting the improved safety profile of PK-TURP, we studied 
patients with older age, larger prostate volumes, and comor-
bidities such as HT, CAD, DM, and COPD who underwent the 
PK-TURP procedure in two institutions. In our study, despite 
the older age, larger prostate volumes, and higher IPSS in the 
PK-TURP group, variations in Hb level at postoperative 24 
hours, serum sodium at perioperative 2 hours, and IPSS at 
postoperative 12 months were significantly lower with higher 
IIEF scores at postoperative 12 months. This was explained 
as follows. First, unintended stimulation of nearby nerves 
during monopolar resection may be avoided with bipolar re-
section. Second, bipolar energy may offer some advantages 
with respect to the reduction of conductive trauma (i.e., tissue 
charring), because the high-frequency current generated by 
a bipolar instrument tends to remain superficial (depth, 0.5–1 
mm) compared with the current generated by a monopolar 
device (depth, 3–5 mm) [17,18]. This superficial depth and ab-
sence of a return current with the PK-TURP instrument may 
reduce the risk of burns, which consequently decreases ure-
thral or bladder neck stricture rates.
 In a very recent study, urethral stricture was found in 9 
patients (7.3%) from the M-TURP arm and 12 patients (7.1%) 
from the PK-TURP arm [19]. Bladder neck contracture oc-
curred in 3 patients (2.4%) from the M-TURP arm and 2 pa-
tients (1.2%) from the PK-TURP arm. The age and prostate 
volumes in both M-TURP and PK-TURP groups were similar 
in this series. In contrast with previous reports, our study 
revealed higher urethral stricture rates in the PK-TURP arm 
than in the M-TURP arm. It is worth mentioning that the 
strictures were confined to the pendular urethra, whereas no 
bladder neck strictures were seen in our patients. 
 Because the bipolar current remains superficial and pro-
vokes lower conductive trauma, the high incidence of ure-
thral strictures might be explained by mechanical trauma. 
Table 3. Distribution of comorbidities in M-TURP and PK-TURP 
patients with urethral stricture complication 
Comorbidity
Urethral stricture
Total
Absent Present
HT 137 3 140
HT+CAD 24 3* 27
COPD 29 1 30
DM 27 0 27
HT+CAD+DM 28 10* 38
HT+CAD+COPD 12 1 13
HT+DM 19 4* 23
HT+DM+COPD 2 1 3
DM+COPD 3 0 3
HT+COPD 13 0 13
Total 294 23 317
P-value 0.000
M, monopolar; PK, plasmakinetic; TURP, transurethral resection of the 
prostate; HT, hypertension; CAD, coronary artery disease; COPD, chronic 
obstructive pulmonary disease; DM, diabetes mellitus.
 *P<0.05.
Table 4. Multivariate analysis of risk factors in M-TURP and PK-
TURP patients with urethral stricture complication 
Risk factor OR 95% CI P-value
Age 1.253 1.046–1.272 0.004
Prostate volume 1.053 1.030–1.076 0.000
HT+DM 9.917 1.646–59.743 0.012
HT+CAD 1.638 0.274–9.786 0.589
HT+ DM+CAD 14.959 3.427–65.303 0.000
M, monopolar; PK, plasmakinetic; TURP, transurethral resection of the 
prostate; OR, odds ratio; CI, confidence interval; HT, hypertension; DM, 
diabetes mellitus; CAD, coronary artery disease. 
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However, the mean operative times in both groups were 
similar, although the prostate volume in the PK-TURP arm 
was higher and the time interval for a given unit of resected 
tissue was shorter. This could be interpreted as meaning that 
urethral tissues were exposed to similar duration of trauma 
by both the M-TURP and PK-TURP resectoscope shafts. Nev-
ertheless, we speculate that either increased age in the PK-
TURP arm or increased frequency and speed in the back and 
forth movements of the bipolar resectoscope by the operator 
(owing to improved vision and hemostasis) may be respon-
sible for the increased stricture rates. Additionally, HT and/or 
CAD and/or DM are conditions that affect the vital supply of 
tissues including the urethra and that could be potential risk 
factors for the occurrence of urethral stricture.
 There were limitations to our study. First, it was retrospec-
tive in nature, and second, the mean preoperative prostate 
volume and age were higher in the PK-TURP group than in 
the M-TURP group.
 In conclusion, PK-TURP is effective for treating BPH pa-
tients having comorbidities with the additional advantages 
of reduced early postoperative complications and superior 
clinical outcome compared with M-TURP. However, the sig-
nificantly higher urethral stricture rates in the PK-TURP group 
deserve further investigation. Furthermore, bipolar resec-
tion of larger prostates in elderly patients with HT+DM and 
HT+CAD+DM should be performed cautiously.
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